These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 12927226

  • 1. AT1 antagonism by eprosartan lowers heart rate variability and baroreflex gain.
    Heusser K, Vitkovsky J, Schmieder RE, Schobel HP.
    Auton Neurosci; 2003 Aug 29; 107(1):45-51. PubMed ID: 12927226
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
    Brooks DP, Ruffolo RR.
    J Hypertens Suppl; 1999 Jun 29; 17(2):S27-32. PubMed ID: 10465064
    [Abstract] [Full Text] [Related]

  • 3. The clinical profile of the angiotensin II receptor blocker eprosartan.
    Hedner T.
    J Hypertens Suppl; 2002 Jun 29; 20(5):S33-8. PubMed ID: 12184062
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin blockade with eprosartan: vascular and functional implications.
    Ram CV.
    Curr Med Res Opin; 2007 Nov 29; 23 Suppl 5():S5-11. PubMed ID: 18093408
    [Abstract] [Full Text] [Related]

  • 5. Elevation of sympathetic activity by eprosartan in young male subjects.
    Heusser K, Vitkovsky J, Raasch W, Schmieder RE, Schobel HP.
    Am J Hypertens; 2003 Aug 29; 16(8):658-64. PubMed ID: 12878372
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Central inhibition of AT1receptors by eprosartan--in vitro autoradiography in the brain.
    Muders F, Palkovits M, Bahner U, Kirst I, Elsner D, Jandeleit-Dahm K.
    Pharmacol Res; 2001 Mar 29; 43(3):251-5. PubMed ID: 11401417
    [Abstract] [Full Text] [Related]

  • 8. Losartan increases bradykinin levels in hypertensive humans.
    Campbell DJ, Krum H, Esler MD.
    Circulation; 2005 Jan 25; 111(3):315-20. PubMed ID: 15655136
    [Abstract] [Full Text] [Related]

  • 9. Management of hypertension: the advent of a new angiotensin II receptor antagonist.
    Hedner T.
    J Hypertens Suppl; 1999 Jun 25; 17(2):S21-5. PubMed ID: 10465063
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Adrenal angiotensin: origin and site of generation.
    van Kats JP, Chai W, Duncker DJ, Schalekamp MA, Danser AH.
    Am J Hypertens; 2005 Aug 25; 18(8):1104-10. PubMed ID: 16109325
    [Abstract] [Full Text] [Related]

  • 12. Impaired neuronal and vascular responses to angiotensin II in a rabbit congestive heart failure model.
    Nap A, Belterman CN, Mathy MJ, Balt JC, Pfaffendorf M, van Zwieten PA.
    J Renin Angiotensin Aldosterone Syst; 2003 Dec 25; 4(4):220-7. PubMed ID: 14689369
    [Abstract] [Full Text] [Related]

  • 13. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
    Murdoch DR, McDonagh TA, Farmer R, Morton JJ, McMurray JJ, Dargie HJ.
    Am Heart J; 2001 May 25; 141(5):800-7. PubMed ID: 11320369
    [Abstract] [Full Text] [Related]

  • 14. A dose-response study to assess the renal hemodynamic, vascular, and hormonal effects of eprosartan, an angiotensin II AT1-receptor antagonist, in sodium-replete healthy men.
    Ilson BE, Boike SC, Martin DE, Freed MI, Zariffa N, Jorkasky DK.
    Clin Pharmacol Ther; 1998 Apr 25; 63(4):471-81. PubMed ID: 9585802
    [Abstract] [Full Text] [Related]

  • 15. Effect of eprosartan on catecholamines and peripheral haemodynamics in subjects with insulin-induced hypoglycaemia.
    Christensen M, Ibsen H, Worck R.
    Clin Sci (Lond); 2005 Feb 25; 108(2):113-9. PubMed ID: 15383007
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Introduction: The pharmacological profile of eprosartan--implications for cerebrovascular and cardiovascular risk reduction.
    de la Sierra A, Ram CV.
    Curr Med Res Opin; 2007 Nov 25; 23 Suppl 5():S1-3. PubMed ID: 18093407
    [Abstract] [Full Text] [Related]

  • 19. Re: Heusser et al: elevation of sympathetic activity by eprosartan in young male subjects.
    Rupp H.
    Am J Hypertens; 2004 Mar 25; 17(3):281; author reply 281-3. PubMed ID: 15001205
    [No Abstract] [Full Text] [Related]

  • 20. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
    Punzi HA, Punzi CF.
    J Hum Hypertens; 2004 Sep 25; 18(9):655-61. PubMed ID: 15042114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.